Zhejiang Difference Biological Technology Co., Ltd. (DIFF Biotech) announced that its proprietary nasal spray influenza attenuated live vaccine, DIFF-flu, has recently received clinical trial approval ...

H5N1 avian influenza, commonly known as bird flu, has long ceased to be just a problem for birds. Since its arrival in the ...

A new nasal spray vaccine for H5N1 bird flu has shown promising early results, raising hopes it could one day be used to help ...

A Phase 2 trial is testing a weekly intranasal spray that primes early immune defenses to reduce respiratory virus illness.

The next fight against COVID and the flu may be as simple as the spritz of a nasal spray containing non-drug ingredients already used in other similar products. Researchers at Harvard and Brigham and ...

Researchers at WashU Medicine have developed a nasal vaccine against the highly pathogenic H5N1 avian influenza virus which ...

A virus-agnostic nasal spray called ‘INNA-051’ was designed to increase innate immunity and prevent respiratory illnesses ...

* Scientists engineered a way to deliver genes directly to lung and airway cells using a nasal spray * AAV.CCP.16 -// a viral vector outperformed older tools like AAV6 and AAV9, offering a safer, ...

ETHealthworld.com brings latest nasal spray news, views and updates from all top sources for the Indian Health industry.

SAN FRANCISCO -- A new type of COVID-19 therapy is showing promise as a new tool to hijack the virus and slow down variants. It's a new weapon that could be added to the arsenal against COVID-19.

Please provide your email address to receive an email when new articles are posted on . In addition to shortening the length of illness, use of nasal spray meant fewer workdays lost. Adults assigned ...